EKF Diagnostics Holdings (GB:EKF) has released an update.
EKF Diagnostics Holdings plc, a global diagnostics company, announced the successful passing of all resolutions at its Annual General Meeting (AGM), with overwhelming shareholder support as indicated by the high percentage of votes in favor. The AGM voting results reflected strong backing for the company’s proposed courses of action, including special resolutions. EKF, known for its point-of-care analyzers in hematology and diabetes as well as life sciences services, operates out of Penarth with additional manufacturing sites in the US and Germany, serving over 120 countries.
For further insights into GB:EKF stock, check out TipRanks’ Stock Analysis page.
